These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 35795156)

  • 1. Inflammation Can Be a High-Risk Factor for Mucosal Nonunion of MRONJ by Regulating SIRT1 Signaling When Treated with an Oncologic Dose of Zoledronate.
    Zhu S; Cui Y; Zhang W; Ji Y; Li L; Luo S; Cui J; Li M
    Drug Des Devel Ther; 2024; 18():2793-2812. PubMed ID: 38979400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial effects of hydroxyapatite and Tualang honey on medication-related osteonecrosis of the jaw (MRONJ): An in vitro study.
    Fauzi MSA; Sabri MSA; Halim AAA; Abidin SAIZ
    J Stomatol Oral Maxillofac Surg; 2024 Jul; ():101999. PubMed ID: 39089510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Biomedical Importance of the Missing Pathway for Farnesol and Geranylgeraniol Salvage.
    Verdaguer IB; Crispim M; Hernández A; Katzin AM
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36557825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Geranylgeraniol in Managing Bisphosphonate-Related Osteonecrosis of the Jaw.
    Chin KY; Ekeuku SO; Trias A
    Front Pharmacol; 2022; 13():878556. PubMed ID: 35600875
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Rattanawonsakul K; Bullock G; Bolt R; Claeyssens F; Atkins S; Hearnden V
    Front Oral Health; 2022; 3():892615. PubMed ID: 35795156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geranylgeraniol (GGOH), incorporated into a bone cement pellet promotes osteoclast function and healing in a model of medication-related osteonecrosis of the jaw.
    Feldman G; Young D; Freeman T; Israel L; Taub D; Diecidue R
    J Oral Biol Craniofac Res; 2024; 14(2):126-132. PubMed ID: 38327595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geranylgeraniol (GGOH) as a Mevalonate Pathway Activator in the Rescue of Bone Cells Treated with Zoledronic Acid: An In Vitro Study.
    Fliefel RM; Entekhabi SA; Ehrenfeld M; Otto S
    Stem Cells Int; 2019; 2019():4351327. PubMed ID: 30728841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro.
    Bullock G; Miller C; McKechnie A; Hearnden V
    Materials (Basel); 2020 May; 13(9):. PubMed ID: 32369961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisphosphonates.
    Jung J; Park JS; Chun J; Al-Nawas B; Ziebart T; Kwon YD
    Life (Basel); 2023 Jun; 13(6):. PubMed ID: 37374134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Association of Oral and Maxillofacial Surgeons' Position Paper on Medication-Related Osteonecrosis of the Jaws-2022 Update.
    Ruggiero SL; Dodson TB; Aghaloo T; Carlson ER; Ward BB; Kademani D
    J Oral Maxillofac Surg; 2022 May; 80(5):920-943. PubMed ID: 35300956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.
    Bullock G; Miller CA; McKechnie A; Hearnden V
    Front Oral Health; 2021; 2():822411. PubMed ID: 35224540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geranylgeraniol prevents zoledronic acid-mediated reduction of viable mesenchymal stem cells via induction of Rho-dependent YAP activation.
    Singhatanadgit W; Hankamolsiri W; Janvikul W
    R Soc Open Sci; 2021 Jun; 8(6):202066. PubMed ID: 34113452
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.